These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10566067)

  • 1. FK 633. FR 144633.
    Drugs R D; 1999 May; 1(5):375-6. PubMed ID: 10566067
    [No Abstract]   [Full Text] [Related]  

  • 2. Fradafiban. BIBU 52, BIBU 52 ZW.
    Drugs R D; 1999 May; 1(5):377-8. PubMed ID: 10566068
    [No Abstract]   [Full Text] [Related]  

  • 3. Roxifiban. DMP 754, MK 0853, XJ 754.
    Drugs R D; 1999 May; 1(5):385-6. PubMed ID: 10566071
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.
    Hennan JK; Hong TT; Willens DE; Driscoll EM; Giboulot TA; Lucchesi BR
    Br J Pharmacol; 2002 Jul; 136(6):927-37. PubMed ID: 12110617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP 9201.
    Drugs R D; 1999 May; 1(5):390-1. PubMed ID: 10566073
    [No Abstract]   [Full Text] [Related]  

  • 6. Lamifiban.
    Drugs R D; 1999 May; 1(5):379-82. PubMed ID: 10566069
    [No Abstract]   [Full Text] [Related]  

  • 7. Sibrafiban. RO 483657, RO 483657-000, Xubix.
    Drugs R D; 1999 May; 1(5):387-9. PubMed ID: 10566072
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet glycoprotein IIb/IIIa antagonists: perioperative implications.
    Sreeram GM; Sharma AD; Slaughter TF
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):237-40. PubMed ID: 11312488
    [No Abstract]   [Full Text] [Related]  

  • 9. Invited commentary.
    Hiramatsu Y
    Ann Thorac Surg; 2005 Jul; 80(1):257-8. PubMed ID: 15975377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
    Zettl H; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and synthesis of an orally active GPIIb/IIIa antagonist based on a phenylpiperazine scaffold.
    van Maarseveen JH; den Hartog JA; Tipker K; Reinders JH; Brakkee J; Schön U; Kehrbach W; Kruse CG
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1531-6. PubMed ID: 9873384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet GPIIbIIIa prolongs survival of discordant cardiac xenografts.
    Lesnikoski BA; Candinas D; Hancock WW; Otsu I; Siegel J; Bach FH; Robson SC
    Transplant Proc; 1996 Apr; 28(2):703. PubMed ID: 8623355
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-platelet and anti-thrombosis characteristics of Z4A5, a novel selective platelet glycoprotein IIb/IIIa inhibitor, compared with eptifibatide under long-term infusion.
    Shi XL; Shen S; Guo MM; Zhang GJ; Che J; Wang B; Zhou J
    Pharmazie; 2015 Dec; 70(12):810-4. PubMed ID: 26817279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
    Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Rescue platelet glycoprotein IIb/IIIa inhibitor therapy in thrombosis complicating superficial femoral artery angioplasty.
    Grollman JH; Coil A
    Cardiovasc Intervent Radiol; 2002; 25(1):77-80. PubMed ID: 11907783
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery.
    Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T
    Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides].
    Marrakchi N; Guermazi S; El Ayeb M
    Arch Inst Pasteur Tunis; 1997; 74(1-2):9-15. PubMed ID: 15945171
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice.
    Iwatsuki Y; Kawasaki T; Hayashi K; Moritani Y; Nii T; Miyata K
    Thromb Haemost; 2004 Dec; 92(6):1221-8. PubMed ID: 15583727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions.
    Ferguson JJ; Zaqqa M
    Drugs; 1999 Dec; 58(6):965-82. PubMed ID: 10651385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.